As a chiral precursor for the important anticoagulant Edoxaban, enantioselective synthesis of ()-3-cyclohexene-1-carboxylic acid is of great significance. The complicated procedures and generation of massive solid waste discourage its chemical synthesis, and the alternative biocatalysis route calls for an enzyme capable of asymmetric hydrolysis of racemic methyl-3-cyclohexene-1-carboxylate. To this end, we engineered the esterase BioH for improved -enantioselectivity via rational design.
View Article and Find Full Text PDF